Pharma companies are collaborating to boost the power of artificial intelligence (AI) in drug discovery by allowing access to ...

The U.K. Medicines and Healthcare Products Regulatory Agency has decided to lean into personalized medicine with the adoption of the concept of a “preference zone” for determining when a therapy can ...

Medtronic plc’s Brainsense adaptive deep brain stimulation system has been shown to be tolerable, effective and safe for long-term use at home in people with Parkinson’s disease. A study published in ...

While the discussions and votes at the past two meetings of the U.S. CDC Advisory Committee for Immunization Practices (ACIP) have generated a lot of controversy and resulted in some states and ...

Human rhinovirus (HRV) is the most frequent cause of upper respiratory infections and a key trigger of asthma exacerbations. No effective anti-HRV therapies exist, and vaccine efforts have been ...

Convatec Group plc plans to invest more than $1 billion in the U.S. and U.K. over the next decade as it looks to accelerate ...

The market for colorectal cancer screening tests seems poised to heat up considerably with a recent request for Medicare ...

A U.S. FDA complete response letter (CRL) citing manufacturing concerns has stepped into the way of a rare genetic disorder ...

Many patients who survive myocardial infarction go on to experience heart failure. Researchers at Qilu Hospital of Shandong ...

CSPC Pharmaceutical Group Ltd. has obtained clearance from China’s National Medical Products Administration (NMPA) to conduct ...

Debiopharm SA has exercised its option to license Sunrock Biopharma SL’s SRB-21, a bispecific HER3/HER2 antibody.

Generating gametes from nonreproductive tissues could help overcome infertility. Previous studies have successfully ...